Ultragenyx Pharmaceutical | RARE - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -162.1M 164.84M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Kyowa Hakko Kirin JPY 13.92B 25.37B 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Moderna USD -1.33B 535M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03